Difficulty: Medium
Average Score: 69%
Practice
Domperidone differs from metoclopramide in
Correct answer
B
Rationale
The correct answer is B) Less extrapyramidal adverse reactions.
Domperidone differs from metoclopramide as it does not readily cross the blood-brain barrier (BBB), resulting in a lower incidence of central nervous system side effects such as extrapyramidal symptoms. Metoclopramide, on the other hand, can cause extrapyramidal adverse reactions due to its ability to block D2 receptors in the brain.
Option A) Does not block D2 receptors is incorrect because domperidone actually does not cross the BBB to block D2 receptors centrally, which is why it has a lower risk of extrapyramidal adverse effects compared to metoclopramide.
Option C) Crosses BBB more readily is incorrect as it is the opposite of the characteristic that distinguishes domperidone from metoclopramide. Domperidone has poor BBB penetration compared to metoclopramide.
Option D) Induces constipation rather than diarrhea is incorrect as both domperidone and metoclopramide can lead to gastrointestinal side effects, but the key difference lies in their propensity for causing extrapyramidal symptoms.
Understanding the differences between these two medications is crucial in clinical practice to make informed decisions when selecting the most appropriate medication for patients with gastrointestinal motility disorders. This knowledge helps healthcare professionals optimize patient care by minimizing adverse effects and maximizing therapeutic benefits.
Domperidone differs from metoclopramide as it does not readily cross the blood-brain barrier (BBB), resulting in a lower incidence of central nervous system side effects such as extrapyramidal symptoms. Metoclopramide, on the other hand, can cause extrapyramidal adverse reactions due to its ability to block D2 receptors in the brain.
Option A) Does not block D2 receptors is incorrect because domperidone actually does not cross the BBB to block D2 receptors centrally, which is why it has a lower risk of extrapyramidal adverse effects compared to metoclopramide.
Option C) Crosses BBB more readily is incorrect as it is the opposite of the characteristic that distinguishes domperidone from metoclopramide. Domperidone has poor BBB penetration compared to metoclopramide.
Option D) Induces constipation rather than diarrhea is incorrect as both domperidone and metoclopramide can lead to gastrointestinal side effects, but the key difference lies in their propensity for causing extrapyramidal symptoms.
Understanding the differences between these two medications is crucial in clinical practice to make informed decisions when selecting the most appropriate medication for patients with gastrointestinal motility disorders. This knowledge helps healthcare professionals optimize patient care by minimizing adverse effects and maximizing therapeutic benefits.